Scientists comment on the launch of a trial by LifeArc to test whether a finger prick test could be used to help diagnose Alzheimer’s disease before symptoms begin.

Personalised healthcare is both the future and the present, says James Goolnik – and diagnostics, he argues, are the key to ...

Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Venture capitalist Meltem Demirors isn’t above the occasional splurge on bags, jewelry and other material things. But she ...

Turns out, living longer might require a village..

After almost 40 years in nursing, much of it spent in cardiology, using a defibrillator machine was second nature to Fran Murt.

The firm at the JP Morgan Healthcare Conference additionally expects a regulatory decision on its gene therapy RGX-121 for Hunter syndrome next month.

A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...

Researchers have discovered novel biomarkers that could allow doctors to detect endometriosis in its earliest stages through ...

A blood test, combined with an ultrathin material derived from graphite, could significantly advance efforts to detect ...

A new blood marker reflects the extent of brain injury after an ischemic stroke and can predict patient outcomes months to ...